Holen Sie sich die Stockscreener-App
535.38
1.15%
6.09
Vorhandelsmarkt:
530.01
-5.37
-1.00%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories stock holds near recent highs as diagnostics demand supports growth - AD HOC NEWS
Down 16% in the Last 12 Months, Can IDEXX Stock Bounce Back in 2027? - TIKR.com
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring A 30% Upside Potential - DirectorsTalk Interviews
IDEXX Laboratories stock gains after strong Q2 results and raised 2026 outlook - AD HOC NEWS
ETFs Investing in IDEXX Laboratories, Inc. Stocks - TradingView
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock steadies after strong Q2 2026 results and raised outlook - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm as investors eye earnings history - AD HOC NEWS
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound? - Eastern Progress
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm after earnings beat - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Resilient IDEXX Laboratories stock holds above $550 as earnings beat supports guidance - AD HOC NEWS
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories Inc. (IDXX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - Barchart.com
Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K - Benzinga
IDEXX Laboratories, Inc. (IDXX) Stock Report: Analyzing a 25.50% Potential Upside for Savvy Investors - DirectorsTalk Interviews
IDEXX Laboratories stock holds high valuation as earnings outlook firms - Ad-hoc-news.de
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView
IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 - 富途牛牛
Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDXX Stock Price and Chart — NASDAQ:IDXX - TradingView
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com
IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune
Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com
NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc Stock Historical Valuations | HAM:IX1 - GuruFocus
IDEXX Laboratories Inc Stock Baskets - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data - GuruFocus
0.59%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):